Publications

Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk . and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2026), Lancet, 407, 1699 - 1711

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016.

Probert J. et al, (2025), J Pathol Clin Res, 11

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988–2016

Probert J. et al, (2025), Journal of Pathology Clinical Research, 11

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

McGale P. et al, (2025), BMJ, 390

Patients need information on the risk of second cancer after early breast cancer.

MacKenzie M. et al, (2025), BMJ, 390

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.

Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2023), Lancet, 402, 1991 - 2003

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882

Authors' reply to Oke and Welch.

Darby SC. et al, (2023), BMJ, 382

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Risk of breast cancer death after a diagnosis of early invasive breast cancer.

MacKenzie M. et al, (2023), BMJ, 381

Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?

Kirby AM. et al, (2023), BMJ, 381

Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting.

Kirby AM. et al, (2023), Clin Oncol (R Coll Radiol), 35, 347 - 350

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk . and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) ., (2023), Lancet, 401, 1277 - 1292

Cookies on this website

Search results (86)